Primary Non-Function (PNF) After Liver Transplantation
Summary of Lecture by Prof. Sanjaya Satapathy, MD, FAASLD
1. Main Clinical Topic(s) Discussed
Primary Non-Function (PNF) of a liver allograft following transplantation — encompassing definition, pathophysiology, clinical recognition, differential diagnosis, and management, with emphasis on board examination preparation and real-world clinical decision-making.
2. Key Learning Points, Guidelines, and Recommendations
Definition
- PNF is severe, irreversible graft failure occurring within the first 72 hours post-transplant, in the absence of an identifiable vascular cause
- The graft never establishes meaningful synthetic, metabolic, or excretory function
- Must be distinguished from Early Allograft Dysfunction (EAD), Ischemia-Reperfusion Injury (IRI), and Hepatic Artery Thrombosis (HAT)
Clinical Features (Red Flags — "Early Progressive Collapse")
- Persistent or worsening lactic acidosis (lactate fails to clear post-reperfusion)
- Absent or minimal bile production (a functioning graft produces bile almost immediately)
- Worsening coagulopathy (INR persistently rising, often >2–3; clotting factors not synthesized)
- Hemodynamic instability requiring escalating vasopressors
- Failure to recover mental status or progressive encephalopathy
- No stabilization phase — this is the defining clinical feature
Pathophysiology and Risk Factors
- PNF results from overwhelming hepatocellular injury due to severe ischemia compounded by reperfusion injury
- Key risk factors:
- Donation after Circulatory Death (DCD) grafts — warm ischemia before procurement
- Prolonged cold ischemia time — one of the strongest predictors
- Donor steatosis — macrosteatosis particularly increases susceptibility
- Older donor age — aging hepatocytes tolerate ischemic stress poorly
- Marginal/extended criteria donors — reduced physiologic reserve
3. Specific Clinical Data, Statistics, and Study Results Cited
| Parameter | EAD | PNF |
|---|
| AST/ALT | >2,000 U/L | Often 5,000–10,000+ U/L |
| INR | ≥1.6 at post-op Day 7 | Rises immediately and severely, does not stabilize |
| Lactate | Mildly elevated, clears | Persistently elevated, does not clear |
| Hemodynamics | Generally stable | Unstable, escalating vasopressors |
| Recovery potential | Possible | Unlikely without retransplant |
| Timeline | Recognized by Day 7 | Declares within first 72 hours |
- Without retransplantation: mortality is extremely high
- With timely retransplantation: survival is achievable — emphasizing that time is the critical variable
4. Practical Takeaways for Clinicians
Diagnostic Approach
- Urgent Doppler ultrasound is mandatory in any patient with severe early graft dysfunction — must confirm hepatic artery patency, portal vein flow, and rule out technical/anastomotic complications before labeling as PNF
- If Doppler shows absent arterial flow → diagnosis is HAT (surgically correctable)
- If Doppler shows intact arterial flow + clinical collapse with no recovery → suspect PNF
- Rule out vascular and mechanical causes before attributing failure to PNF
Management
- Supportive care (hemodynamic stabilization, vasopressors, FFP/cryoprecipitate/platelets, CRRT for AKI) is necessary but not definitive
- The only definitive treatment is urgent retransplantation
- PNF qualifies for UNOS Status 1A listing (acute graft failure classification)
- Do not delay with biopsy, steroids, or watchful waiting — proceed to